| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $31.1M | +13.5% | +8.8% |
| R&D Expense | $1.6M | +55.3% | +98.0% |
| SG&A Expense | $4.9M | +12.1% | +11.6% |
| Operating Income | $3.2M | +7.1% | -1.7% |
| Pre-tax Income | $3.1M | +5.4% | -1.9% |
| Income Tax | $43K | +2.4% | +4.9% |
| Net Income | $3.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $15.3M | +12.9% | +27.7% |
| Inventory | $605K | +15.7% | +17.7% |
| Current Assets | $29.3M | -5.9% | +29.1% |
| Total Assets | $90.6M | +20.4% | +28.1% |
| Current Liabilities | $23.2M | +42.9% | +5.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $19.9M | — | — |
| Capital Expenditures | $2.7M | — | — |
| Investing Cash Flow | -$21.2M | — | — |
| Financing Cash Flow | $1.2M | — | — |
| Free Cash Flow | $17.2M | — | — |
| +5.4% |
| -2.0% |
| EPS (Basic) | $0.04 | +0.0% | +200.0% |
| EPS (Diluted) | $0.04 | +0.0% | +200.0% |
| $32.8M |
| +71.0% |
| +35.5% |
| Stockholders' Equity | $57.8M | +3.1% | +24.3% |